Skip to main content
Top
Published in: Endocrine 1/2022

04-08-2022 | Cushing's Syndrome | Brief report

Unilateral or bilateral adrenalectomy in PPNAD: six cases from a single family followed up over 40 years

Authors: G. Vitellius, B. Donadille, B. Decoudier, A. Leroux, S. Deguelte, S. Barraud, J. Bertherat, B. Delemer

Published in: Endocrine | Issue 1/2022

Login to get access

Abstract

The most frequent endocrine Carney complex manifestation is a bilateral primary pigmented nodular adrenocortical disease and bilateral adrenalectomy (BA) is therefore its main treatment. In this study, a 40 years follow-up of six members of the same family with heterozygous PRKAR1A germline mutation, is reported over two generations. The first cases, two sisters with severe hyperandrogenism and Cushing syndrome (CS) diagnosed in 1972 at age 14 and 25, were successfully treated with unilateral adrenalectomy (UA). Their two brothers were then diagnosed, one with a CS-related severe osteoporosis treated with BA and the other with CS treated with UA. The second generation was diagnosed with CS signs at 7 and 21 years of age and were treated with BA and UA respectively. Out of the four patients treated with UA, the only event possibly related to CS was spontaneous episode of pulmonary embolism, 30 years after surgery. Hormonal evaluation revealed either eucortisolism in one patient or partial adrenal deficiency in two and mild hypercortisolism in one patient. For the two patients with BA, one of them accidentally died. The second one, surprisingly, recovered progressively normal cortisol secretion and circadian variation. Steroid substitution was stopped 6 years after her surgery and we demonstrated by iodocholesterol scintigraphy the presence of bilateral adrenal remnants. In conclusion, our results of long term evolution of PPNAD patients show that UA in this subset of patients could be considered to treat CS.
Literature
2.
go back to reference S. Espiard, M.C. Vantyghem, G. Assié, C. Cardot-Bauters, G. Raverot, F. Brucker-Davis, F. Archambeaud-Mouveroux, H. Lefebvre, M.L. Nunes, A. Tabarin, A. Lienhardt, O. Chabre, M. Houang, M. Bottineau, S. Stroër, L. Groussin, L. Guignat, L. Cabanes, A. Feydy, F. Bonnet, MO. North, N. Dupin, S. Grabar, D. Duboc, J. Bertherat, Frequency and incidence of carney complex manifestations: a prospective multicenter study with a three-year follow-up. J. Clin. Endocrinol. Metab. 105, (2020). https://doi.org/10.1210/clinem/dgaa002 S. Espiard, M.C. Vantyghem, G. Assié, C. Cardot-Bauters, G. Raverot, F. Brucker-Davis, F. Archambeaud-Mouveroux, H. Lefebvre, M.L. Nunes, A. Tabarin, A. Lienhardt, O. Chabre, M. Houang, M. Bottineau, S. Stroër, L. Groussin, L. Guignat, L. Cabanes, A. Feydy, F. Bonnet, MO. North, N. Dupin, S. Grabar, D. Duboc, J. Bertherat, Frequency and incidence of carney complex manifestations: a prospective multicenter study with a three-year follow-up. J. Clin. Endocrinol. Metab. 105, (2020). https://​doi.​org/​10.​1210/​clinem/​dgaa002
3.
go back to reference J. Bertherat, A. Horvath, L. Groussin, S. Grabar, S. Boikos, L. Cazabat, R. Libe, F. René-Corail, S. Stergiopoulos, I. Bourdeau, T. Bei, E. Clauser, A. Calender, L.S. Kirschner, X. Bertagna, J.A. Carney, C.A. Stratakis, Mutations in regulatory subunit type 1A of cyclic adenosine 5’-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J. Clin. Endocrinol. Metab. 94, 2085–2091 (2009). https://doi.org/10.1210/jc.2008-2333CrossRefPubMedPubMedCentral J. Bertherat, A. Horvath, L. Groussin, S. Grabar, S. Boikos, L. Cazabat, R. Libe, F. René-Corail, S. Stergiopoulos, I. Bourdeau, T. Bei, E. Clauser, A. Calender, L.S. Kirschner, X. Bertagna, J.A. Carney, C.A. Stratakis, Mutations in regulatory subunit type 1A of cyclic adenosine 5’-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J. Clin. Endocrinol. Metab. 94, 2085–2091 (2009). https://​doi.​org/​10.​1210/​jc.​2008-2333CrossRefPubMedPubMedCentral
6.
go back to reference M. Cignarelli, G. Picca, M. Campo, M. Margaglione, A. Marino, F. Logoluso, F. Giorgino, A six month mitotane course induced sustained correction of hypercortisolism in a young woman with PPNAD and Carney complex. J. Endocrinol. Investig. 28, 54–60 (2005). https://doi.org/10.1007/BF03345530CrossRef M. Cignarelli, G. Picca, M. Campo, M. Margaglione, A. Marino, F. Logoluso, F. Giorgino, A six month mitotane course induced sustained correction of hypercortisolism in a young woman with PPNAD and Carney complex. J. Endocrinol. Investig. 28, 54–60 (2005). https://​doi.​org/​10.​1007/​BF03345530CrossRef
9.
13.
go back to reference D. Vezzosi, F. Tenenbaum, L. Cazabat, F. Tissier, M. Bienvenu, C.A. Carrasco, M. Laloi-Michelin, G. Barrande, H. Lefebvre, S. Hiéronimus, A. Tabarin, X. Bertagna, P. Legmann, M.C. Vantyghem, J. Bertherat, Hormonal, radiological, np-59 scintigraphy, and pathological correlations in patients with Cushing’s syndrome due to primary pigmented nodular adrenocortical disease (PPNAD). J. Clin. Endocrinol. Metab. 100, 4332–4338 (2015). https://doi.org/10.1210/jc.2015-2174CrossRefPubMed D. Vezzosi, F. Tenenbaum, L. Cazabat, F. Tissier, M. Bienvenu, C.A. Carrasco, M. Laloi-Michelin, G. Barrande, H. Lefebvre, S. Hiéronimus, A. Tabarin, X. Bertagna, P. Legmann, M.C. Vantyghem, J. Bertherat, Hormonal, radiological, np-59 scintigraphy, and pathological correlations in patients with Cushing’s syndrome due to primary pigmented nodular adrenocortical disease (PPNAD). J. Clin. Endocrinol. Metab. 100, 4332–4338 (2015). https://​doi.​org/​10.​1210/​jc.​2015-2174CrossRefPubMed
Metadata
Title
Unilateral or bilateral adrenalectomy in PPNAD: six cases from a single family followed up over 40 years
Authors
G. Vitellius
B. Donadille
B. Decoudier
A. Leroux
S. Deguelte
S. Barraud
J. Bertherat
B. Delemer
Publication date
04-08-2022
Publisher
Springer US
Published in
Endocrine / Issue 1/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03142-4

Other articles of this Issue 1/2022

Endocrine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.